The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients

With the outbreak of a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the public healthcare systems are facing great challenges. Coronavirus disease 2019 (COVID‐19) could develop into severe pneumonia, acute respiratory distress syndrome and multi‐organ failure. Remar...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Hengzhi, Wang, Dao Wen, Chen, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521316/
https://www.ncbi.nlm.nih.gov/pubmed/32713161
http://dx.doi.org/10.1111/jcmm.15674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521316/
https://www.ncbi.nlm.nih.gov/pubmed/32713161
http://dx.doi.org/10.1111/jcmm.15674

Ejemplares similares